Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment. The Company’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccines, neuroscience, pediatrics, and rare and orphan diseases. Synteract has conducted nearly 4,000 studies on six continents in over 62 countries.
Location: United States, North Carolina, Morrisville
Member count: 501-1000
Founded date: 1995
Investors 1
| Date | Name | Website |
| - | Northstar ... | northstarc... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 14.09.2021 | Closing th... | Racial diversity in clinical t... | - | - | prweb.com/... |
| 06.04.2021 | Forward-Fo... | Participants will have a stron... | - | - | prweb.com/... |
| 11.03.2021 | Natural Hi... | As is true for all rare diseas... | - | - | prweb.com/... |
| 03.03.2021 | The Critic... | Since ensuring rating accuracy... | - | - | prweb.com/... |
| - | Wendel Bar... | Synteract, Inc., a full-servic... | - | - | gryphon-in... |